These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36599066)
1. Moving the Needle on Alzheimer's Disease with an Anti-Oligomer Antibody. Gandy S; Ehrlich ME N Engl J Med; 2023 Jan; 388(1):80-81. PubMed ID: 36599066 [No Abstract] [Full Text] [Related]
2. [Advances in anti-beta antibody treatment of Alzheimer's disease]. Zhang JH; Liang P Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):633-5. PubMed ID: 18070457 [No Abstract] [Full Text] [Related]
5. Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice. Xiao S; Song LL; Li JT; Wang H; Yu N; Wang ZQ; Zhang Y; He JS; Hung T J Alzheimers Dis; 2020; 73(2):657-670. PubMed ID: 31839610 [TBL] [Abstract][Full Text] [Related]
6. Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease. Geng J; Li M; Ren J; Wang E; Qu X Angew Chem Int Ed Engl; 2011 Apr; 50(18):4184-8. PubMed ID: 21433228 [No Abstract] [Full Text] [Related]
7. Physiopathological modulators of amyloid aggregation and novel pharmacological approaches in Alzheimer's disease. Defelice FG; Ferreira ST An Acad Bras Cienc; 2002 Jun; 74(2):265-84. PubMed ID: 12098753 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta. Wang J; Hara H; Makifuchi T; Tabira T J Alzheimers Dis; 2008 Jun; 14(2):161-73. PubMed ID: 18560128 [TBL] [Abstract][Full Text] [Related]
9. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice. Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786 [TBL] [Abstract][Full Text] [Related]